These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9387265

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 3. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP.
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA, Pollice AA, Gu LP, Brown KA, Singh SG, Janocko LE, Johnson R, Julian T, Hyams D, Wolmark N, Sweeney L, Silverman JF, Shackney SE.
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [Abstract] [Full Text] [Related]

  • 6. Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.
    Moreno A, Lloveras B, Figueras A, Escobedo A, Ramon JM, Sierra A, Fabra A.
    Mod Pathol; 1997 Nov; 10(11):1088-92. PubMed ID: 9388058
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
    Wärnberg F, Nordgren H, Bergkvist L, Holmberg L.
    Br J Cancer; 2001 Sep 14; 85(6):869-74. PubMed ID: 11556839
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Microsatellite instability in ductal carcinoma in situ of the breast.
    Walsh T, Chappell SA, Shaw JA, Walker RA.
    J Pathol; 1998 May 14; 185(1):18-24. PubMed ID: 9713355
    [Abstract] [Full Text] [Related]

  • 18. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.
    Clin Cancer Res; 1999 May 14; 5(5):1041-56. PubMed ID: 10353737
    [Abstract] [Full Text] [Related]

  • 19. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
    Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR.
    Cancer Res; 2000 Aug 15; 60(16):4346-8. PubMed ID: 10969774
    [Abstract] [Full Text] [Related]

  • 20. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD, Korcum AF, Pestereli E, Erdogan G, Karaveli S, Savas B, Griffith TS, Sanlioglu S.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):716-23. PubMed ID: 17512128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.